Showing results (61-70 of 91) with videos related to
Sort By:
Pageof 10
Analytica Chimica Acta|November 15, 2025
Spatial atlasing of N-glycosylation in healthy control and clear cell renal cell carcinoma tissues linked with immune checkpoint inhibition response by MALDI mass spectrometry imagingCaroline Kittrell, Lyndsay E A Young, Colin McDowell, et al.Cancers|July 15, 2026
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA StudyMarc-Oliver Grimm, Viktor Grünwald, Harald Müller-Huesmann, et al.Cancer Medicine|February 16, 2023
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicityNora Möhn, Susann Mahjoub, Laura Duzzi, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 16, 2018
Bevacizumab-associated glomerular microangiopathyFermin Person, Markus M Rinschen, Silke R Brix, et al.Journal of Neurology|June 12, 2025
Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse eventsLeonie Müller-Jensen, Nora Möhn, Thomas Skripuletz, et al.Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcomeRainer Hamacher, Xiaofei Liu, Markus K Schuler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup StudyViktor Grünwald, Annika Karch, Markus Schuler, et al.Journal of Cancer Research and Clinical Oncology|August 7, 2023
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancerViktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, et al.Cancer Medicine|January 26, 2025
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG StudyJonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.Pageof 10